Physician
Hematology
Dr. Giuseppe Fraschini, MD
|
|
Give Review
Giuseppe Fraschini is an expert in the field of Hematology. He has 1 awards "Super Doctor". Giuseppe Fraschini is also published. He has 53 publications published. The lastest publication: "Phase II study of mitoxantrone by 14-day continuous infusion with granulocyte colony-stimulating factor (GCSF) support in patients with metastatic breast cancer and li...'
Publications
- Chemotherapy following estrogen-induced expansion of the growth fraction of human breast Cancer.
- Randomized comparison between sevoflurane anaesthesia and unilateral spinal anaesthesia in elderly patients undergoing orthopaedic surgery.
- Intravascular device-related infections in Cancer patients.
- Estrogen induced expansion of the growth fraction in receptor negative human breast Cancer.
- Regional intra-arterial chemotherapy of metastatic liver Cancer.
- Acute systemic sclerosis (scleroderma) that mimicked treatment-related complications in a breast cancer patient.
- Percutaneous hepatic arterial infusion of cisplatin for metastatic breast Cancer.
- Hematologic adverse effects of aminoglutethimide.
- Five-day continuous-infusion vinblastine in the treatment of breast Cancer.
- Antiemetic activity of ondansetron in Cancer patients receiving non-cisplatin chemotherapy.
- Peptichemio versus melphalan (L-PAM) in advanced breast Cancer.
- Oral medroxyprogesterone acetate in the treatment of metastatic breast Cancer.
- The M. D. Anderson Cancer Center experience with Taxol in metastatic breast Cancer.
- Percutaneous hepatic arterial infusion of cisplatin-vinblastine for refractory Breast carcinoma metastatic to the liver.
- Phase II study of deoxyspergualin in metastatic breast Cancer.
- Phase II study of iproplatin in metastatic Breast carcinoma.
- Elliptinium acetate in metastatic breast Cancer--a phase II study.
- Syndrome of inappropriate antidiuretic hormone secretion associated with hepatic arterial infusion of vinblastine in three patients with breast Cancer.
- Phase I-II study of high-dose etoposide in patients with refractory breast Cancer.
- Chemotherapy-induced neutropenia and fever in patients with metastatic Breast carcinoma receiving salvage chemotherapy.
- Continuous 5-day infusion of vinblastine for percutaneous hepatic arterial chemotherapy for metastatic breast Cancer.
- Inflammatory carcinoma of the breast: results of a combined-modality approach--M.D. Anderson Cancer Center experience.
- Is chemotherapy effective in reducing the local failure rate in patients with operable breast Cancer?
- Clinical course of patients with breast Cancer with ten or more positive nodes who were treated with doxorubicin-containing adjuvant therapy.
- Phase II study of paclitaxel in patients with metastatic Breast carcinoma refractory to standard chemotherapy.
- Phase II evaluation of gallium nitrate by continuous infusion in breast Cancer.
- Cisplatin in combination with continuous infusion vinblastine for refractory breast Cancer.
- Clinical course of breast Cancer patients with liver metastases.
- Paclitaxel by 24-hour infusion with doxorubicin by 48-hour infusion as initial therapy for metastatic breast Cancer: phase I results.
- Local infusion of urokinase for the lysis of thrombosis associated with permanent central venous catheters in Cancer patients.
- The myeloprotective effect of recombinant human granulocyte-macrophage colony-stimulating factor given sequentially with continuous infusion vinblastine in metastatic ...
- c-erbB-2 amplification in node-negative human breast Cancer.
- Phase I-II study: triciribine (tricyclic nucleoside phosphate) for metastatic breast Cancer.
- Phase II clinical and pharmacological study of pirarubicin in combination with 5-fluorouracil and cyclophosphamide in metastatic breast Cancer.
- Secondary drug resistance in breast Cancer: failure to reverse with oral nifedipine.
- Pirarubicin in combination chemotherapy for metastatic breast Cancer.
- Chemotherapy with mitoxantrone in combination with continuous infusion vinblastine for metastatic breast Cancer.
- Sequential multiagent chemotherapy incorporating cisplatin, doxorubicin, and cyclophosphamide in the treatment of metastatic breast Cancer.
- Phase II study of mitoxantrone by 14-day continuous infusion with granulocyte colony-stimulating factor (GCSF) support in patients with metastatic breast Cancer and li...
- Doxorubicin-induced congestive heart failure in elderly patients with metastatic breast Cancer, with long-term follow-up: the M.D. Anderson experience.
- Combined antiestrogen and cytotoxic therapy with pseudomonas vaccine immunotherapy for metastatic breast Cancer. A prospective, randomized trial.
- Adjuvant therapy of breast Cancer with or without additional treatment with alternate drugs.
- A comparative study of doxorubicin and epirubicin in patients with metastatic breast Cancer.
- Management of stage III primary breast Cancer with primary chemotherapy, surgery, and radiation therapy.
- Decreased cardiac toxicity of doxorubicin administered by continuous intravenous infusion in combination chemotherapy for metastatic Breast carcinoma.
- Adjuvant therapy with escalating doses of doxorubicin and cyclophosphamide with or without leukocyte alpha-interferon for stage II or III breast Cancer.
- Evaluation of three oral dosages of ondansetron in the prevention of nausea and emesis associated with cyclophosphamide-doxorubicin chemotherapy.
- Sequence-dependent alteration of doxorubicin pharmacokinetics by paclitaxel in a phase I study of paclitaxel and doxorubicin in patients with metastatic breast Cancer.
- Phase II trial of docetaxel: a new, highly effective antineoplastic agent in the management of patients with anthracycline-resistant metastatic breast Cancer.
- The use of alternate, non-cross-resistant adjuvant chemotherapy on the basis of pathologic response to a neoadjuvant doxorubicin-based regimen in women with operable b...
- Dose-ranging trial with a recombinant urokinase (urokinase alfa) for occluded central venous catheters in oncology patients.
- Fluorouracil, doxorubicin, and cyclophosphamide followed by tamoxifen as adjuvant treatment for patients with stage IV breast Cancer with no evidence of disease.
Schools
Universita Degli Studi Di Pavia Facolta Di Medicina E Chirurgia
Procedures Preformed
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
Conditions Treated
- Acute Leukemia
- Anal and Rectal Cancer
- Anemia
- Bile Duct Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
- Hematology
Accepted Insurances
Awards
- Super Doctor
Education
-
University of Texas Health Science Center -
Advocate Illinois Masonic Medical Center -
University of Pavia Faculty of Medicine
Hospital
-
Houston Northwest Medical Center
Helpful Reviews
Similar Doctors
|
|
Dr. Eugene M. McKelvey, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ethan A. Natelson, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Yasuhiro Oki, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Maro N. Ohanian, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rajul Jain, MD |
|
|
Dr. Anthony Padula, MD |
|
|
Dr. Inhye Ahn, MD
This Doctor is OpenDoctor Recommended.
|